Porcine Derma for Soft Tissue Augmentation Around Implants (NCT07436091) | Clinical Trial Compass
By InvitationNot Applicable
Porcine Derma for Soft Tissue Augmentation Around Implants
Portugal15 participantsStarted 2026-04-01
Plain-language summary
Brief description of the study objectives The present study aims to evaluate the effectiveness of the porcine-derived collagen matrix Derma OsteoBiol® for peri-implant soft tissue augmentation.
The objectives include:
Measuring changes in soft tissue thickness (in 3D) in the buccal region of the treated implants; Analyzing patient-reported outcomes (PROMs), namely pain and impact on oral health-related quality of life; Monitoring the stability of peri-implant tissues and aesthetic parameters over a 12-month period.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Patients must have the ability to fully understand the nature of the proposed surgery, voluntarily consent to participate and signed the Informed Consent Form before any study related procedures are performed.
* Agree with data collection and analyses.
* Males or females who are a minimum of 18 years of age or older.
* Ability to comply with study-related procedures, including maintaining good oral hygiene and attending follow-up appointments.
* Implant placement at least 6 weeks prior to enrolment.
* There must be a need for soft tissue augmentation in an implant side.
* Implant located in the posterior areas of the maxilla or mandibula (molar or 2nd premolars).
* Basic periodontal examination (BPE) score must be less than 2.
* patients exhibiting KT width of \>2 mm at the buccal aspect of the implant.
Exclusion Criteria:
* • Patients who meet any of the following exclusion criteria are not eligible for inclusion in the study.
* General contraindications for dental and/or surgical treatment, including the use of anticoagulants.
* Presence of a vertical bone dehiscence greater than 3 mm at the implant site, as assessed at the time of soft tissue augmentation surgery.
* Heavy smoking habit, defined as consuming more than 10 cigarettes per day.
* Presence of active periodontal or peri-implant disease.
* Insulin-dependent diabetes.
* History of malignancy, radiotherapy, or chemotherapy for malignancy within the past 5 year…